Total Medical devices industry M&A deals worth $2.6bn were announced globally in June 2022, led by ResMed’s $1bn acquisition of MediFox DAN Group, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 164% over the previous month of $1bn and a drop of 63.6% when compared with the last 12-month average, which stood at $7.26bn.
Comparing M&A deals value in different regions of the globe, Europe held the top position, with total announced deals in the period worth $1.14bn. At the country level, the Germany topped the list in terms of deal value at $1.09bn.
In terms of volumes, Europe emerged as the top region for Medical devices industry M&A deals globally, followed by North America and then Asia-Pacific.
The top country in terms of M&A deals activity in June 2022 was the US with 17 deals, followed by the UK with five and Germany with three.
In 2022, as of June, Medical devices M&A deals worth $12.46bn were announced globally, marking an increase of 67.3% year on year.
Medical devices industry M&A deals in June 2022: Top deals
The top five M&A deals accounted for 90.9% of the overall value during June 2022.
The combined value of the top five Medical devices M&A deals stood at $2.4bn, against the overall value of $2.6bn recorded for the month.
The top five Medical devices industry M&A deals of June 2022 tracked by GlobalData were:
1) ResMed $1bn acquisition deal with MediFox DAN Group
2) The $534.27m acquisition of Instituto Hermes Pardini by Fleury
3) Evolent Health $462m acquisition deal with Implantable Provider Group
4) The $230m acquisition of 64% stake in M.I.Tech by Boston Scientific
5) Guardant Health $177.8m acquisition deal with Guardant Health AMEA
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.